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Pseudomonas aeruginosa is one of the most common opportunistic pathogens that use quorum sensing 
(QS) system to regulate virulence factors expression and biofilm development. Delftia sp. 11304 
was selected among 663 Gram-negative clinical isolates based on its QS inhibitory activity against P. 
aeruginosa MMA83 clinical isolate. Whole genome sequencing identified this isolate as D. tsuruhatensis 
and revealed genetic armamentarium of virulence factors and antibiotic resistance determinants. 
Ethyl acetate extract of D. tsuruhatensis 11304 culture supernatant (QSI extract) prevented biofilm 
formation of P. aeruginosa MMA83, but was unable to cause biofilm decomposition. QSI extract showed 
a synergistic effect in combination with meropenem and gentamycin, against P. aeruginosa MMA83. A 
dose-dependent reduction of the virulence factors: elastase, rhamnolipid and pyocyanin production by 
P. aeruginosa MMA83 and significant downregulation of lasI, lasR, rhlI, rhlR, pqs and mvfR expression 
were observed. Matrix-assisted Laser Desorption Ionization (MALDI) mass spectrometry of D. 
tsuruhatensis 11304 QSI extract revealed the presence of N-acyl homoserine lactones (AHL) with chain 
lengths of C12 to C18. The main ion peak was identified as N-octadecanoylhomoserine lactone (c18-
HSL). Commercial C18-HSL (20 µM) reduced pyocyanin production as well as mRNA level of the lasI gene. 
A novel AHL species, dihydroxy-N-octadecanoylhomoserine lactone, was also described.
Pseudomonas aeruginosa is one of the most significant opportunistic pathogens causing nosocomial infec-
tions with high morbidity and mortality, predominantly among immunocompromised and intensive care unit 
patients1–4. Pathogenic potential can be attributed to P. aeruginosa genomic plasticity and versatility which result 
in extensive genetic armamentarium of virulence factors and antibiotic resistance determinants5. Current increase 
in number of health care-associated infections caused by multidrug- (MDR) or extensively drug-resistant (XDR) 
P. aeruginosa isolates, as well as their worldwide spread has been considered as worrisome due to limited ther-
apeutic options6. The lack of efficient therapeutic options for infections caused by MDR/XDR P. aeruginosa is 
driving research towards alternative therapeutic approaches such as targeting social behaviors involved in patho-
genesis as well as bacteriophages and vaccines7,8.
P. aeruginosa cells communicate through quorum sensing (QS) system, i.e. by synthesizing small signal mole-
cules, which depending on the density of the population correlate the regulation of virulence factors expression, 
biofilm development, production of secondary metabolites and interaction with hosts9–11. P. aeruginosa employs 
three major interconnected QS systems that function independently and dependently involving las, rhl, pqs path-
ways as well as novel candidate iqs pathway regulated by several QS signal molecules12. N-acyl homoserine lac-
tones (AHLs) are the best characterized QS signal molecules. Different AHLs possess a homoserine lactone ring 
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with an attached fatty acyl side chain of 4 to 20 carbons13,14. Detection of AHLs occurs either directly by LuxR reg-
ulators within the cell, or by membrane-bound two-component histidine kinase-type proteins15,16. Interestingly, 
long-chain AHLs, C10-AHL, C12-AHL and C14-AHL, were reported to bind to CviR AHL receptor in widely used 
reporter system Chromobacterium violaceum CV026 with the same affinity as C6-AHL autoinducer, but they 
disrupt activity of CviR in terms of transcriptional activation17,18. Disruption of QS achieved by interference with 
QS signaling or interception of signal molecules is considered a key point for development of antibacterial and 
anti-disease strategies targeting pathogens like P. aeruginosa in medicine19. Indeed, interference with QS signaling 
by QS-inhibitors (QSI) or interception of signal molecules by quorum quenching enzymes (QQE) results in a 
reduction of virulence regulated by QS. It is considered that QSI is a natural mechanism first developed either by 
QS-emitting organisms for the recycling or clearing of their own QS signals or by QSI organisms in the context 
of a competitive relationship with QS-signal-emitting organisms. Thus, bacteria that share ecological niche with 
P. aeruginosa during infections could be considered as promising producers of novel QSI molecules. Examples of 
the activity of QSI molecules, showing a successful reduction of siderophores, proteases, rhamnolipids secretion, 
as well as inhibition of biofilm formation have been previously documented. While those studies were mainly 
focused on P. aeruginosa PAO1 and PA14 model strains9,20,21 a still limited number of studies reported effects of 
QSI molecules on P. aeruginosa clinical isolates, especially MDR or XDR strains22. Diverse sources of QSI mole-
cules that inhibit the virulence of P. aeruginosa have been described so far, both biogenic including plants, animals 
and bacteria23–25 or derived by chemical synthesis26.
Delftia tsuruhatensis strains have previously been investigated as plant growth-promoting rhizobacteria 
(PGPR) due to their production of siderophores which can mitigate iron limitation in soil27. However, recent 
findings pinpoint D. tsuruhtensis as an emerging pathogen associated with an increasing number of human infec-
tions28–30. It was previously published that D. tsuruhatensis could exhibit an anti-quorum sensing activity to P. 
aeruginosa quorum sensing systems, and authors identified a diisooctyl ester of 1,2 benzenedicarboxylic acid as 
an active compound31. Herein we analyzed inhibitory potential of D. tsuruhatensis11304 clinical isolate against 
QS systems of P. aeruginosa MDR clinical isolate and characterized molecule(s) underlying this phenomenon.
Results
clinical isolate Delftia sp. 11304 produces QSI molecule(s). Among 633 clinical isolates from a 
Laboratory collection screened for quorum sensing inhibitory (QSI) activity (Supplementary Table 1) 19 strains 
(belonging to five genera) were selected as positive (Supplementary Table 2). Delftia sp. 11304 was selected as 
one of the most promising candidate with QSI activity. Growth phase dependence of the Delftia sp. 11304 QSI 
phenotype was determined, as the QSI phenotype could not be detected before 4 hours of growth, while the peak 
of QSI activity was observed after16 hours (corresponding to the stationary phase). High production of QSI 
molecule(s) was retained after up to 30 hours of growth (Fig. 1). As a control QSI activity of previously charac-
terized QSI molecules produced by Delftia tsuruhatensis: bis (2-ethylhexyl) phthalate and diisooctyl phthalate 
were tested in parallel. Neither of these compounds showed QSI activity at the used concentrations (ranging from 
4 µg/ml to 1024 µg/ml) when tested in a colorimetric agar well diffusion assay using Chromobacterium violaceum 
CV026 as an indicator strain (Supplementary Fig. S1). Additionally, no measurable effects of bis (2-ethylhexyl) 
phthalate and diisooctyl phthalate neither on the viability of C. violaceum CV026 and P. aeruginosa MMA83 
(Supplementary Table S3) nor to P. aeruginosa MMA83 biofilm production were detected (Supplementary 
Fig. S2).
Whole genome sequencing. Genomic DNA of the strain Delftia sp. 11304 was sequenced using Illumina 
HiSeq. 2500 platform (MicrobesNG, University of Birmingham, United Kingdom). A total of 6,616,336 sequences 
were generated from the genome. Assembly of reads resulted in 199 contigs with the largest contig 337425 and 
an average GC content of 66.78%. The contig dataset was used to determine the functional analysis. According 
Figure 1. Growth phase dependence of QSI production by Delftia sp. 11304. Bacterial growth curve was 
determined by enumerating of colony forming units (CFU) at selected time points. Dependence of QSI activity 
from growth phase was determined at the same time points and expressed as numerical values obtained by 
measurement of inhibition zones of violacein production by Chromobacterium violaceum CV026.
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to the genomic sequence analysis Delftia sp. 11304 was identified as a Delftia tsuruhatensis species. A reper-
toire of different virulence factors and antibiotic resistance determinants were detected in D. tsuruhatensis 11304 
genome (Supplementary Tables 4 and 5). Among the virulence factors presence of the genes encoding for dif-
ferent siderophores, pyoverdine, pyochelin and ornitobactin, as well as capsule and alginate could be pointed 
out. Additionally, within the D. tsuruhatensis 11304 resistome antibiotic resistance determinants such as genes 
encoding for efflux pumps of Resistance-Nodulation-Division (RND) superfamily (including: mexF, mexY, mexB, 
mexD, mexI, mexA, smeB, smeE, amrB and mdtB), beta-lactamases genes blaOXA-258 and blaLRA-13, as well as spira-
mycin resistance gene were identified as the most significant.
Stability of the QSI molecule(s). In order to determine whether D. tsuruhatensis 11304 QSI activity was 
based on proteinaceous or non-proteinaceous molecule activity, thermostability and resistance to proteinase were 
tested. Results showed that both overnight culture and cell-free supernatant retained QSI activity after the heat 
and proteinase K treatments (Fig. 2). Obtained results suggested that the QSI activity of D. tsuruhatensis 11304 
was based on non-enzymatic quorum sensing inactivation mechanism.
ethyl acetate D. tsuruhatensis 11304 extract exhibits QSI activity and inhibits biofilm forma-
tion of P. aeruginosa MMA83. Organic solvents with different polarity were used to optimize the extrac-
tion of the QSI molecule(s) from D. tsuruhatensis 11304 overnight culture supernatant. Only the ethyl acetate 
extract resuspended in DMSO was shown to be QSI active (Fig. 2), while methanol, chloroform and hexane 
extracts did not exhibit any QSI activity.
To exclude that the QSI effect of extract was a result of a bactericidal effect on the P. aeruginosa MMA83, we 
evaluated the antimicrobial activity of the QSI extract by microdilution method. As shown in Fig. 3, D. tsuruhat-
ensis 11304 QSI ethyl acetate extract had no statistically significant effect on the P. aeruginosa MMA83 growth.
Additionally, we have demonstrated that the inhibition of P. aeruginosa MMA83 biofilm formation by D. 
tsuruhatensis 11304 was dose-dependent using crystal violet staining of biofilm biomass (Fig. 3). Indeed, biofilm 
formation decreased by 88.5% in the presence of 5 mg/ml QSI extract comparing to the control (***p < 0.001). 
About 50% inhibition of biofilm formation was observed with a 0.156 mg/ml QSI extract (***p < 0.001). The 
lowest tested concentration of QSI extract (0.038 mg/ml) showed decreasing activity of 21.9% in regard to positive 
control (*p < 0.05). Treatment of P. aeruginosa MMA83 with the highest dose of DMSO used in experiment (0.5% 
v/v) had no statistically significant impact on bacterial growth and biofilm formation.
D. tsuruhatensis 11304 QSI extract prevents biofilm formation of P. aeruginosa MMA83, but 
it is unable to induce biofilm decomposition. Fluorescence microscopy has been used to visualize the 
effect of the QSI extract on P. aeruginosa MMA83 biofilm formation as well as on the decomposition of preformed 
biofilm. The captured images showed that P. aeruginosa MMA83 that grew in the absence of D. tsuruhatensis 
11304 QSI extract formed a compact biofilm. In the presence of D. tsuruhatensis 11304 QSI extract biofilm was 
highly dispersed, with a clear decrease in the surface coverage and density of bacteria. Indeed, as shown in Fig. 4, 
minimal attachment of P. aeruginosa MMA83 cells could be observed in the treatment with a 5 mg/ml QSI extract 
(after 24 hours of incubation) (Fig. 4b).
Figure 2. D. tsuruhatensis 11304 QSI activity was determined using colorimetric agar well diffusion assay 
with Chromobacterium violaceum CV026 as an indicator strain. (a) The activity of untreated control of D. 
tsuruhatensis 11304 overnight culture (1) and cell-free supernatant (2). The heat treatment at 100 °C for 30 min 
(3, 4) and 60 min (5, 6). D. tsuruhatensis 11304 overnight culture (3, 5) and cell-free supernatant (4, 6) retained 
QSI activity and shown to be thermostable. Proteinase K treatment did not affect QSI activity of D. tsuruhatensis 
11304 overnight culture (7) and cell-free supernatant (8). Ethyl acetate extract of D. tsuruhatensis 11304 
exhibits QSI activity (9). Proteinase K and LB growth medium with 0.5% DMSO (10, 11) are used as negative 
controls. (b) Quantitative data of these experiments obtained by measurement of inhibition zones of violacein 
production by Chromobacterium violaceum CV026.
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Interestingly, co-incubation of preformed P. aeruginosa MMA83 biofilm with the QSI extract (5 mg/ml) did 
not result in decomposition of the biofilm (Fig. 4d), although the biofilm architecture was less consistent and 
slightly different compared to the positive control (Fig. 4c), there were still visible living bacterial cells resembling 
the architecture observed in the positive control.
Figure 3. The effect of the D. tsuruhatensis 11304 QSI extract on P. aeruginosa MMA83 biofilm formation 
ability measured by crystal violet staining. The D. tsuruhatensis 11304 QSI extract inhibits biofilm formation in 
a dose-dependent manner. P. aeruginosa MMA83 cell growth is represented by white (logCFU/ml), and biofilm 
formation by gray bars (OD595). Numbers on x-axis represent two-fold serial dilutions of the D. tsuruhatensis 
11304 QSI extract with the unit of measure being mg/ml. DMSO – bacterial culture with 0.5% v/v of DMSO 
that is the highest concentration of DMSO in experiment (used when 5 mg/ml of QSI extract was added). Data 
analysis by Student’s t- test demonstrates significant difference (*p < 0.05, **p < 0.01, ***p < 0.001) between the 
treated biofilms and the control (DMSO treated control). No significant difference in the cell growth between 
treated and untreated controls was observed.
Figure 4. The effect of the D. tsuruhatensis 11304 QSI extract on P. aeruginosa MMA83 biofilm formation (a,b) 
and decomposition of preformed biofilms (c,d), captured with fluorescence microscopy. P. aeruginosa MMA83 
was coincubated for 24 hours with 5 mg/ml D. tsuruhatensis 11304 QSI extract in order to visualize its effects on 
biofilm forming ability. The effect of the D. tsuruhatensis 11304 QSI extract on decomposition of 24 hours old 
preformed biofilm was evaluated after 24 hours of treatment with QSI extract. Fluorescent dyes SYTO9 (green) 
and PI (red) were used for the visualization of biofilms. Scale bar represents 10 µm.
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D. tsuruhatensis 11304 QSI extract shows synergistic effect with antibiotics. In order to inves-
tigate the clinical relevance of the QSI extract and its effectiveness in combination with clinically used drugs, the 
checkerboard method was assessed. Results indicate that the test strain P. aeruginosa MMA83 was susceptible 
to meropenem and gentamycin at very high used concentrations (MIC values 0.512 mg/ml and 4.096 mg/ml, 
respectively). MIC value of the D. tsuruhatensis QSI extract was 20 mg/ml. However, their combined applica-
tion with the QSI extract showed a synergistic outcome for meropenem (∑FIC = 0.125) and for gentamycin 
(∑FIC = 0.047) (Table 1). DMSO (MIC value 145.45 mg/ml) had indifferent outcome for both of used antibiotics.
D. tsuruhatensis 11304 QSI extract inhibits the virulence factors production of P. aeruginosa 
MMA83. The impact of the QSI extract on the QS regulated virulence factors (elastase, rhamnolipid and pyo-
cyanin) production in P. aeruginosa MMA83 was next investigated. A dose-dependent decrease in the production 
of all the analyzed virulence factors was observed (Fig. 5). The lack of the production of elastase, rhamnolipid and 
pyocyanin after treatment of the P. aeruginosa MMA83 strain with a 5 mg/ml D. tsuruhatensis 11304 QSI extract 
has been noticed. The treatment with a 0.156 mg/ml QSI extract resulted in about 40% inhibition of rhamnolipid 
and 50% inhibition of elastase and pyocyanin production compared to the positive control.
D. tsuruhatensis 11304 QSI extract inhibits the expression of P. aeruginosa MMA83 QS systems. 
In order to confirm that the above described effects of D. tsuruhatensis 11304 QSI extract on P. aeruginosa 
MMA83 virulence were caused by transcriptional inhibition of QS systems genes belonging to three P. aeruginosa 
QS networks (las – lasI, lasR; rhl – rhlI, rhlR; PQS – pqs, mvfR) were selected for RT-qPCR study. The obtained 
results revealed that the treatment of P. aeruginosa MMA83 with a 5 mg/ml QSI extract significantly decreased the 
mRNA levels (***p < 0.001) (Fig. 6). Relative expression of the genes coding for inducer synthases lasI and rhlI 
was 2.2 times lower, while the expression of transcriptional regulators lasR and rhlR was even more reduced (7.6 
and 4.1 times lower, respectively) compared to the control. The most significant downregulation of transcription 
was observed in the case of the pqs gene (15 times lower), while the transcription of transcriptional regulator 
mvfR was 5.7 times lower compared to the control.
Antimicrobials
Pseudomonas aeruginosa MMA83
MIC of each antimicrobial (mg/ml)
FIC ∑FIC OutcomeAlone Combination
QSI extract 20 1.25 0.0625 0.125 synergistic
Meropenem 0.512 0.032 0.0625
DMSO 145.45 145.45 1 3 indifferent
Meropenem 0.512 1.024 2
QSI extract 20 0.625 0.03125 0.047 synergistic
Gentamycin 4.096 0.064 0.0156
DMSO 145.45 145.45 1 2 indifferent
Gentamycin 4.096 4.096 1
Table 1. The checkerboard method representing the effect of antimicrobials against P. aeruginosa MMA83. 
FIC – fractional inhibitory concentration, FIC = MIC combination/MIC alone. ∑FIC – sum of two FICs, 
∑FIC = FIC of antibiotic + FIC of QSI extract or DMSO.
Figure 5. Graph demonstrating the dose-dependent effect of the D. tsuruhatensis 11304 QSI extract on P. 
aeruginosa MMA83 virulence factors production. Black bars – production of elastase, white bars – production 
of rhamnolipid and gray bars – production of pyocyanin. Statistical significance was evaluated by Student’s t- 
test against control (0) without QSI extract (*p < 0.05, **p < 0.01, ***p < 0.001).
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Determination of D. tsuruhatensis 11304 QSI extract composition by MALDI mass spectrom-
etry. To define the nature of the molecules composing the D. tsuruhatensis 11304 QSI extract, an aliquot of 
the sample was preliminarily purified on a thin-layer chromatography (TLC) silica gel. Separated spots were 
visualized, and then scratched off. The silica gel was put into a cotton-plugged column, and the sample was eluted 
from the gel by ethyl acetate, dried and then investigated by MALDI mass spectrometry. Several solvents were 
employed to dilute and analyze the QSI extract; nevertheless, the best resolved spectra were obtained by diluting 
the QSI extract directly in the matrix solution (see Methods section for details).
The positive ion MALDI mass spectrum, recorded in reflectron mode, is reported in Fig. 7a. The spec-
trum clearly indicated the presence of several [M + H]+ ions attributed to N-acyl homoserine lactones 
(AHLs) with chain lengths of C12 to C18. In particular, the main ion peak at m/z 368.3 was identified as 
N-octadecanoylhomoserine lactone (C18-HSL). This was proven by the observation in the related positive 
ion MS2 spectrum (Supplementary Fig. S3) of (i) the typical intense ion at m/z 102.06, common to all AHLs 
detected, relative to the protonated α-amino-γ-butyrolactone deriving from the cleavage of the carboxamide 
linkage between the acyl chain and the homoserine group; (ii) the counterpart acylium ion arising from the 
same cleavage (m/z 267.27) as well as (iii) the occurrence of a fragment originated from the loss of a water 
molecule from the [M + H]+ molecular ion (m/z 350.29)32,33. Similarly, other AHLs species with a shorter acyl 
chain have been identified at m/z 284.2 (C12-HSL), m/z 312.3 (C14-HSL) and m/z 340.3 (C16-HSL). In traces, 
Figure 6. The changes of relative mRNA levels of QS genes without or with the treatment of P. aeruginosa 
MMA83 with a 5 mg/ml D. tsuruhatensis 11304 QSI extract. Genes examined in this study belong to three P. 
aeruginosa QS pathways (las – lasI, lasR; rhl – rhlI, rhlR; PQS – pqs, mvfR). RT-qPCR data were normalized 
against the ribosomal gene rpsL as an internal control. Student’s t- test was used to compare the differences 
between the control and experimental groups (***p < 0.001).
Figure 7. MALDI MS investigation of the D. tsuruhatensis 11304 QSI extract. (a) Positive ion MALDI MS 
spectrum recorded in reflectron mode of the D. tsuruhatensis 11304 QSI extract. (b) Positive ion MS2 spectrum 
of precursor ion at m/z 400.3. The relative AHL structure is reported in the inset. The position of the hydroxyl 
groups is tentative.
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N-3-oxo-octadecanoylhomoserine lactone (oxo-C18-HSL) has also been detected at m/z 382.3 (Fig. 7a). In addi-
tion, a clearly intense peak at m/z 400.3 was noted and isolated as MS2 precursor ion furnishing important struc-
tural data. The corresponding MALDI MS2 spectrum (Fig. 7b), revealed the occurrence of the common ion at m/z 
102.06 but also of an ion derived from the loss of water from the protonated molecular ion (m/z 382.29).
c18-HSL reduces pyocyanin production and quorum sensing lasI gene expression in P. aerug-
inosa MMA83. In order to investigate QSI potential of C18-HSL its effect on expression of quorum sens-
ing genes and pyocyanin production in P. aeruginosa MMA83 was analyzed. Small but statistically significant 
decrease in pyocyanin production by MMA83 grown in presence of 20 µM C18-HSL was observed (Fig. 8b). In 
addition, the same concentration of C18-HSL statistically significant reduced transcription of the lasI gene in 
MMA83, although the fold-change was small (Fig. 8a).
Discussion
Our understanding of Delftia tsuruhatensis has experienced a complete turnaround from the promising plant 
growth-promoting bacteria to emerging human pathogen predominantly isolated from respiratory specimens, 
blood and urine27,30. There is a disparity between the growing importance of Delftia spp. isolates and genomic data 
from these species. Noticeably, D. tsuruhatensis genomic data are scarce since only the genome of D. tsuruhatensis 
MTQ3 is publicly available on NCBI. Although we could not speculate about the origin of the D. tsuruhatensis 
11304 strain, which was characterized in this study (was it intrahospital, or an environmental strain introduced 
to the hospital by a patient), the presence of genetic determinants for the production of siderophores, capsule and 
alginate is a good indication of a possible virulent phenotype. Along with the genetic determinants of antibiotic 
resistance that were found within the D. tsuruhatensis 11304 genome, like beta-lactamases and RND pumps, that 
could contribute to the overall pathogenicity of this particular strain and could provide insight into the genetic 
armory of D. tsuruhatensis in general.
The reason why we included Delftia spp. in testing was our initial presumption that bacteria, like D. tsuruhat-
ensis 11304, which colonize the same tissues during infection of a host as P. aeruginosa, probably compete with P. 
aeruginosa by employing diverse mechanisms, including the interference of cell-to-cell signaling, i.e. quenching 
of the quorum sensing systems. Diisooctyl ester of 1,2 benzenedicarboxylic acid, a compound that is called by 
several different names, was previously identified as a QSI molecule, produced by Delftia tsuruhatensis, active 
against P. aeruginosa PAO1 QS31. It is worth noticing that a contamination of laboratory samples by this com-
pound was found when plastic tubes were used, since it is widely used as a plasticizer34,35. In addition, our data 
showed that within the range of concentrations used in this study, bis (2-ethylhexyl) phthalate and diisooctyl 
phthalate were unable to interfere with C. violaceum CV026 quorum sensing system or with P. aeruginosa biofilm 
formation. Thus, our main aim was to characterize the QSI potential of D. tsuruhatensis 11304 against P. aerugi-
nosa by using C. violaceum and a multidrug-resistant clinical isolate P. aeruginosa MMA83 as model systems. The 
D. tsuruhatensis 11304 ethyl acetate extract showed a remarkable ability to attenuate P. aeruginosa MMA83 QS, 
and to suppress its virulent phenotype by disabling its intrinsic ability to form a biofilm or to produce virulence 
factors such as elastase, rhamnolipid and pyocyanin.
Biofilm formation ability of P. aeruginosa MMA83 was significantly impaired by the D. tsuruhatensis 11304 
extract, without affecting overall bacterial cell growth. This reduction in biofilm forming ability occurred in a 
dose-dependent manner, similarly as previously reported for other QSI extracts36,37. However, the disruption of 
preformed biofilm was not achieved, which might result from biofilm matrix impermeability or possibility that 
it acts through QS inhibition. The production of extracellular virulence factors is of crucial importance for the 
invasion of host tissues, initial phases of biofilm formation and promoting virulence expression and it was shown 
Figure 8. The QSI effect of commercial C18-HSL to P. aeruginosa MMA83. (a) The changes of relative mRNA 
levels of QS genes without or with the treatment of P. aeruginosa MMA83 with commercial C18-HSL. Genes 
examined in this study belong to three P. aeruginosa QS pathways (las – lasI, lasR; rhl – rhlI, rhlR; PQS – mvfR). 
RT-qPCR data were normalized against the ribosomal gene rpsL as an internal control. (b) The changes in 
pyocyanin production after the treatment of P. aeruginosa MMA83 with a commercial C18-HSL. “C” on both 
graphs refers to the DMSO control. Student’s t- test was used to compare the differences between the control and 
experimental groups (*p < 0.05, **p < 0.01, ***p < 0.001).
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to be controlled by las and rhl QS systems38,39. Our study demonstrated that the D. tsuruhatensis 11304 extract was 
highly capable of attenuating P. aeruginosa virulence, and thus possibly infection, by significantly reducing the 
production of these virulence factors. This anti-virulent effect of the D. tsuruhatensis 11304 extract was based on 
the inhibition on transcriptional level of las, rhl and pqs QS systems, indicating a possible therapeutic potential of 
the QSI molecule(s) produced by strain 11304.
Considering that clinical isolates of P. aeruginosa often possess MDR or even XDR resistant phenotype, novel 
strategy for clinical treatment of infections caused by such isolates could be the combination of antibiotics with 
non-antibiotic bioactive compounds. It has been reported that different QS inhibitors caused a decrease in anti-
biotic resistance in P. aeruginosa PAO1 through synergistic effects with clinically used drugs40,41. In our study, 
susceptibility of the MDR clinical isolate P. aeruginosa MMA83 to meropenem and gentamycin was enhanced by 
synergistic interactions of the D. tsuruhatensis 11304 QSI extract with antibiotics.
MALDI MS data showed that AHLs with chain lengths of C12 to C18 were present in the D. tsuruhaten-
sis 11304 QSI extract, with the main ion peak attributed to N-octadecanoylhomoserine lactone (C18-HSL). 
Interestingly, peak at m/z 400.3 was noted and isolated as MS2 precursor ion furnishing important structural 
data. The corresponding MALDI MS2 spectrum (Fig. 7b), revealed the occurrence of the common ion at m/z 
102.06 but also of an ion derived from the loss of water from the protonated molecular ion (m/z 382.29). Two 
peaks at m/z 281.25 and 263.24, matching with the loss of one and two water molecules respectively from the 
acyl chain, suggested the occurrence of two hydroxyl groups decorating the acyl chain. None of the fragments 
helped in understanding the position of the two hydroxyl moieties; nevertheless, according to literature data, 
it could be assumed that a single hydroxyl group is placed at position 3 of the acyl chain whereas the position 
of the second remains to be defined. Therefore, a novel AHL species could be identified as composing the D. 
tsuruhatensis 11304 QSI extract, specifically a dihydroxy-N-octadecanoylhomoserine lactone (Fig. 7b). Although 
C18-HSLs were previously described42, to our best knowledge this is the first report of a naturally occurring 
dihydroxy-N-octadecanoylhomoserine lactone. Finding that commercial C18-HSL reduces lasI quorum sens-
ing gene expression and pyocyanin production indicates its involvement in virulent potential of P. aeruginosa 
MMA83. This finding is of importance since it is known that, in certain bacterial species, long-chain AHLs 
interfere with the short-chain AHLs-mediated QS signaling17,18. For example, C10-HSL fails to activate the 
CviR-dependent transcription in C. violaceum CV026, and yet functions as an antagonist in the presence of a 
native autoinducer C6-HSL. Additionally, it was shown that the lengthening of the AHLs’ acyl-tails in the CV026 
model system reduces agonism and enhances antagonism due to the promotion of an inactive conformation of 
the CviR:ligand complex43. It is tempting to speculate that the long-chain AHLs in the D. tsuruhatensis 11304 
extract, among which a predominantly novel dihydroxy-N-octadecanoylhomoserine lactone is present, could 
be responsible for the interference of the P. aeruginosa MMA83 quorum sensing system and mitigation of its 
virulence. An analogy could be drawn to the CV026 quorum sensing system since P. aeruginosa doesn’t produce 
AHLs with side chains longer than C1244. Our findings could be also supported with observations made by Zhu 
et al.45, who showed that one of the strongest antagonists of TraR, which is a 3-oxo-C8-HSL-responsive transcrip-
tional activator in Agrobacterium tumefaciens, had also hydroxyl residues placed at position 3 of the acyl chain. 
The authors of mentioned study also claimed that the length of the side acyl chain was one of key determinants 
affecting antagonistic properties of synthetic AHLs used in their model system. We should take into account that 
the observed QSI activity could not be attributed solely to C18-HSL but to an orchestrated activity of several mol-
ecules from the extract, due to limited effect of C18-HSL comparing to the effect of entire 11304 QSI extract. Thus, 
our further work will be focused on the separation and identification of all the components in D. tsuruhatensis 
11304 ethyl acetate extract, and testing of their QSI activities independently.
Methods
Bacterial strains and cultivation conditions. Strain Delftia sp. 11304 from the collection of Laboratory 
for Molecular Microbiology (LMM), Institute of Molecular Genetics and Genetic Engineering (IMGGE), 
University of Belgrade, used in this study was isolated in a co-culture with Achromobacter xylosoxidans 11304 
from a cough swab46 in a tertiary type hospital in Belgrade, Serbia. Quorum sensing inhibition (QSI) activity of 
633 clinical isolates from LMM collection was tested by using AHL biosensor strain Chromobacterium violaceum 
026 (CV026), a mini-Tn5 mutant deficient in the AHLs synthase cvil17. Pseudomonas aeruginosa MMA83, a New 
Delhi metallo-beta-lactamase-producing clinical strain from the laboratory collection (LMM, IMGGE) was used 
as a test strain47,48. The bacteria were cultured aerobically in either Luria–Bertani (LB) broth medium or Mueller-
Hinton medium (MH) at 37 °C for all isolates except C. violaceum CV026 which was grown at 30 °C. M9 medium 
(10 x M9 salts - Na2HPO4x7H2O, KH2PO4, NaCl, NH4Cl; 20% glucose; 1 M MgSO4; 1 M CaCl2; dissolved in miliQ 
water) supplemented with 0.24% pyruvate was used for bacterial cultivation on a large scale for extraction of 
molecule(s) that interfere with quorum sensing system.
QSI detection assay. Initial screening for Delftia sp. 11304 QSI activity was performed with colorimetric 
agar well diffusion assay using Chromobacterium violaceum CV026 as an indicator strain. Overnight culture 
of C. violaceum CV026 (0.5% v/v) was inoculated in Luria-Bertani soft-agar (0.5% v/v) with addition of 5 μM 
N-(hexanoyl)-l-homoserine lactone – HHL (Sigma-Aldrich, Missouri, USA) and overlaid on LB agar (17% v/v). 
Wells were made in lawn of the solidified LB soft agar. Wells were filled with 50 μl of Delftia sp. 11304 culture and 
incubated for 24 h at 30 °C in order to test QSI activity49. The absence of the violet color around the wells was con-
sidered as evidence of the inhibition of violacein pigment synthesis, and demonstrative of positive QSI activity.
QSI activity of Delftia sp. 11304 was monitored during different growth phases. Initially, 1% overnight culture 
was inoculated in fresh LB medium and grown at 37 °C, with aeration for 30 hours. Aliquots of bacterial culture 
were collected at different time points (0, 2, 4, 6, 8, 10, 12, 14, 16, 24 and 30 hours) and serial tenfold dilutions were 
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prepared for determination of CFU/ml number. In parallel, QSI activity was determined by colorimetric agar well 
diffusion assay where diameter of QS inhibition was measured. Experiment was done in triplicate.
Chemical compounds bis (2-ethylhexyl) phthalate and diisooctyl phthalate that possess the same molecular 
formula C24H38O4 (molecular weight 390.564 g/mol) and the same structural formula (diisooctyl phthalate) as a 
previously described quorum sensing inhibitor compound31 were used in order to confirm their QSI and anti-
bacterial activity. Two-fold serial dilutions (started from 1024 µg/ml to 4 µg/ml) of bis (2-ethylhexyl) phthalate 
and diisooctyl phthalate solutions (Sigma-Aldrich) dissolved in ethanol (1:1 ratio)-were tested for antibacterial 
activity on C. violaceum CV026 and P. aeruginosa MMA83, QSI activity (C. violaceum CV026) as well as biofilm 
forming effect (P. aeruginosa MMA83) using previously described methods.
Whole genome sequencing and genome analyses. Genomic DNA of Delftia sp. 11304 was 
sequenced using Illumina HiSeq by MicrobesNG service (MicrobesNG, IMI-School of Biosciences, University of 
Birmingham, Birmingham, UK). The quality of each sequencing library was assessed using FastQC50. IDBA-UD 
with multi k-mer mode outperformed the assembly using De Bruijn Graph methods51. In addition, unassembled 
reads were collected and assembled by Celera Assembler with the Best Overlap Graph-CABOG. Finally, raw 
reads were mapped to assembled scaffolds with Burrows Wheeler Aligner- BWA52. Delftia sp. 11304 was identified 
using the genome sequence and EzBioCloud 16 S rRNA gene database available online at https://help.ezbiocloud.
net/ezbiocloud-16s-database/53.
Identification of genes coding virulence factors in the genome sequence was performed using virulence factor 
database (VFDB), an online resource for curating information about virulence factors of bacterial pathogens 
(http://www.mgc.ac.cn/VFs/main.htm)54 and Linux command line. Presence of the antibiotic resistance genetic 
determinants in the sequenced genome was determined by the publicly available database, The Comprehensive 
Antibiotic Resistance Database (CARD, https://card.mcmaster.ca/)55 using Linux command line. Draft genome 
sequence of Delftia tsuruhatensis 11304 has been deposited at the NCBI GenBank database under accession num-
ber SMMJ00000000.
Stability of D. tsuruhatensis 11304 QSI molecule(s). In order to test the thermostability of D. tsuruhat-
ensis 11304 QSI activity, overnight culture and cell-free supernatant were incubated at 100 °C for 30 and 60 min. 
Additionally, a potential proteinaceous nature of QSI activity was tested by treatment of D. tsuruhatensis 11304 
overnight culture and cell-free supernatant with proteinase K (500 μg/ml) at 37 °C for 3 hours. Residual QSI activ-
ities after the heat or proteinase K treatments were evaluated by colorimetric agar well diffusion assay.
Preparation of the D. tsuruhatensis 11304 QSI extract. Bacterial culture D. tsuruhatensis 11304 (five 
liters) was cultivated in M9 medium supplemented with 0.24% pyruvate for 24 h, at 37 °C, aerobically. After cen-
trifugation at 13,680 x g, at 4 °C, for 30 min, the collected supernatant was divided into four glass flasks and each 
of them was extracted with an equal volume of methanol, chloroform, ethyl acetate and hexane (Sigma-Aldrich) 
with vigorous shaking for 30 min at room temperature. Extracts were evaporated to dry using a vacuum rotary 
evaporator at 50 °C for ethyl acetate and 30 °C for methanol, chloroform and hexane (Buchi Rotavapor, R200, 
Fisher Scientific, Hampton, New Hampshire, US) and the dry mass was dissolved in dimethyl sulfoxide (DMSO) 
for further analyses56,57. In order to avoid contamination with phthalates from plasticware all experiments were 
done in glassware.
The effect of the D. tsuruhatensis 11304 QSI extract on P. aeruginosa MMA83 biofilm forma-
tion ability. In order to determine the minimal inhibitory concentration (MIC) of ethyl acetate QSI extract 
dissolved in DMSO on P. aeruginosa MMA83 planktonic cells, a 5 mg/ml QSI extract (following two-fold serial 
dilutions) was inoculated with 2 × 105 CFU/ml of the test strain using a 96-wells microdilution method. The MIC 
value was defined as the lowest concentration which inhibited bacterial growth. Controls were incubated with a 
concentration of DMSO equal to that used in the treatment (0.5% v/v). Number of CFU/ml was determined by 
plating serial tenfold dilutions after 24 h of incubation at 37 °C. The experiments were performed in sextuplicate 
and repeated three times. Afterwards, wells were washed to remove planktonic bacterial cells and stained with 
0.1% (v/v) crystal violet (HiMedia Labs Pvt. Ltd., India)58. Biofilm formation was quantified by recording the 
absorbance at 595 nm using Plate Reader Infinite 200 pro (MTX Lab Systems, Austria).
The effects of the QSI extract on biofilm formation or decomposition of preformed biofilm were additionally 
visualized using fluorescent dye SYTO9 (TermoFisher Scientific, Massachusetts, USA) and propidium iodide 
(PI) (Sigma-Aldrich)59. For visualization of biofilms, P. aeruginosa MMA83 (2 × 105 CFU/ml) was cocultivated 
with a 5 mg/ml QSI extract in 24-well plates (Tissue Culture Plate, Sarstedt, Germany) which contained micro-
scopic cover glass. After incubation (24 h, at 37 °C), the cells were washed 3 times with PBS and stained with 
SYTO9 (2.5 µM) and PI (2.5 µM), green and red fluorescent dyes, respectively. In order to test the decomposition 
of preformed biofilm in the presence of the QSI extract, P. aeruginosa MMA83 was cultivated for 24 hours, at 
37 °C in 24-well plates, washed 3 times with PBS and, subsequently, treated with 5 mg/ml of QSI extract. After 
next 24 hours (48 hours in total), cells were washed and stained as previously described. Stained cells were vis-
ualized by fluorescence microscope (Olympus BX51, Applied Imaging Corp., San Jose, California, USA) under 
20,000 × magnification. Untreated bacterial cells were used as a positive control.
QSI extract effect on antibiotic MIC values against P. aeruginosa MMA83. The combined effect 
of the D. tsuruhatensis 11304 QSI extract and selected, clinically relevant antibiotics against P. aeruginosa 
MMA83 were assessed using 96-well plate microdilution method. Serial dilutions of meropenem (2.048, 1.024, 
0.512, 0.256, 0.128, 0.064, 0.032, 0.016, 0.008, 0.004 or 0.002 mg/ml) or gentamycin (4.096, 2.048, 1.024, 0.512, 
0.256, 0.128, 0.064, 0.032, 0.016, 0.008, 0.004 or 0.002 mg/ml) were cross-diluted with serial dilutions of QSI 
extract (20, 10, 5, 2.5, 1.25, 0.625, 0.312, 0.156, 0.076 or 0.038 mg/ml) and DMSO (16, 8, 4, 2, 1, 0.5%). Different 
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concentrations of DMSO were expressed in mg/ml (16% corresponds with 145.45 mg/ml, etc.) in order to calcu-
late final outcome for fractional inhibitory concentration. Plates (Tissue Culture Plate, Sarstedt, Germany) were 
filled with the bacterial suspension at a final density of 2 × 105 CFU/ml. Cell density was recorded by OD600 meas-
urements using Plate Reader Infinite 200 pro (MTX Lab Systems, Austria) after 24 hours of incubation at 37 °C. 
The experiments were performed in triplicate and repeated two times.
The fractional inhibitory concentrations (FICs) were determined according to the previously described check-
erboard method60.The outcome was defined as a synergistic if the sum of two FICs (FIC of the antibiotic and FIC 
of the QQ extract) was ≤ 0.5; additive if 0.5 < ∑FIC ≤ 1; indifferent if 1 < ∑FIC < 4; antagonistic if ∑FIC > 4.
The effect of the D. tsuruhatensis 11304 QSI extract on the virulence factors production in P. 
aeruginosa MMA83. Elastase assay. Supernatants of overnight culture of Pseudomonas aeruginosa MMA83 
were supplemented with two-fold diluted concentrations of the QSI extract (starting with 5 mg/ml, down to 
0.038 mg/ml) and then mixed with Elastin-Congo red (Sigma-Aldrich) at a final concentration of 2 mg/ml. After 
24 h of incubation at 37 °C, with shaking (180 rpm), the mixtures were centrifuged at 15,700 x g for 15 min, 
after which the elastase activity was measured at 495 nm using Plate Reader Infinite 200 pro (MTX Lab Systems, 
Austria)61. Supernatant of P. aeruginosa MMA83 culture without the QSI extract treatment was used as a positive 
control.
Rhamnolipid assay. Rhamnolipid production was examined by acidification of supernatants with HCl (to pH 
2) of the previously cultivated test strain (co-incubated with two-fold serial dilutions of the QSI extract or without 
the QSI extract)62. The absorbance was monitored spectrofotometrically at 570 nm by Plate Reader Infinite 200 
pro (MTX Lab Systems, Austria).
Pyocyanin assay. P. aeruginosa MMA83 overnight culture (with two-fold dilutions of the QSI extract or with-
out the QSI extract) was centrifuged at 15,700 x g for 15 min and pyocyanin was extracted from the superna-
tant using chloroform in a 1:2 ratio following the re-extraction of chloroform phase by 0.2 N HCl (3:1 ratio) 
according to the previously described method63,64. The concentration of pyocyanin was evaluated by measuring 
the absorbance of the red top layer at 520 nm using Plate Reader Infinite 200 pro (MTX Lab Systems, Austria). 
Concentrations, expressed as micrograms of pyocyanin produced per milliliter of culture supernatant, were 
determined by multiplying the optical density at 520 nm (OD520) by 17.072.
Quantification of P. aeruginosa MMA83 quorum sensing genes expression by RT-qPCR. Reverse 
transcription-quantitative PCR (RT-qPCR) was performed to determine the expression levels of regulatory genes 
involved in quorum sensing. Primers used for the amplification of selected genes are listed in the Table 2. The total 
RNA was isolated from the test strain P. aeruginosa MMA83 (grown for 10 hours, at 37 °C) supplemented with the 
QSI extract (5 mg/ml) or without it by RNeasy Mini Kit (Qiagen, Germany). The total RNA was then treated with 
DNase using an Ambion DNA-freeTM Kit (ThermoFisher, MA, US) and reverse transcribed by a Rever-tAid RT 
Reverse transcription Kit (ThermoFisher) according to the manufacturer’s instructions. Further amplification was 
achieved with KAPA SYBR Fast qPCR Kit (Kapa Biosystems, Wilmington, MA, USA) in a 7500 Real Time PCR 
System (Applied Biosystems, Waltham, MA, USA) under the following cycling conditions: incubation at 95 °C for 
3 min and 40 cycles of 95 °C/15 s and 60 °C/1 min. RT-qPCR data was normalized against the ribosomal gene rpsL 
as an internal control following the 2-ΔΔCtmethod65.
Isolation of QSI molecules by TLC. An aliquot (1 mg) of the D. tsuruhatensis 11304 QSI extract was dis-
solved in 100 µl of ethyl acetate and was applied to TLC (Silica gel 60, F254, Aluminium sheets, Merck, Darmstadt, 
Germany) followed by developing with a mixture of chloroform and ethyl acetate in the ratio 5:4.
Separated spots were scratched off from the plate and the silica gel was put into a cotton-plugged column. The 








































Reverse 5-GCTGTGCTCTTGCAGGTTGTG-3 This study
Table 2. List of primers used for RT-qPCR.
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MALDI MS and MS2 of the D. tsuruhatensis 11304 QSI extract. The MS structural analysis was 
performed on an ABSCIEX TOF/TOFTM 5800 Applied Biosystems mass spectrometer equipped with an 
Nd:YLF laser (λ = 345 nm), with a pulse length of <500 ps and a repetition rate of up to 1000 Hz. The dried 
sample obtained after TLC separation was redissolved either in acetonitrile, ethyl acetate, or directly in an 
α-cyano-4-hydroxycinnamic acid matrix solution (5 mg/ml) in acetonitrile/TFA 0.1% (70:30)32. The prepared 
QSI extract (0.5 µl) and matrix solution (0.5 µl), or 1 µl of the mixture were deposited on a stainless-steel plate and 
left to dry at room temperature. Each spectrum, acquired in positive ion mode, was a result of the accumulation 
of 2,000 laser shots, whereas 2,500 shots were summed for the MS2 data acquisitions.
The effect of the commercial C18-HSL on the pyocyanin production and quantification of quo-
rum sensing genes expression in P. aeruginosa MMA83. Commercial N-octadecanoylhomoserine 
lactone (C18-HSL) was purchased from Cayman Chemical (Tallin, Estonia) and resuspended in DMSO (0.5 mg/
ml) according to manufacturer instructions. Concentrations of 5, 20 and 50 µM C18-HSL were used for evalua-
tion of pyocyanin production and quantification of quorum sensing genes (listed in Table 2) expression in the 
presence of C18-HSL. Each concentration of C18-HSL was compared with control containing the exact volume of 
DMSO without C18-HSL to eliminate biological effect of DMSO in the experiment. Pyocyanin productions was 
expressed in µg/ml as described previously63,64. Experiments were done as described above, in triplicate.
Statistical analyses. The statistical analyses and visualization were performed using GraphPad Prism soft-
ware and SPSS 20.0 for Windows. The results are shown as means ± standard errors. The differences between 
control and experimental groups were compared using Student’s t-test. A p value less than 0.05 was considered to 
be statistically significant.
Received: 14 April 2019; Accepted: 26 October 2019;
Published: xx xx xxxx
References
 1. Araujo, D. et al. The independent contribution of Pseudomonas aeruginosa infection to long term clinical outcomes in bronchiectasis. 
Eur Resp J. 51, 1701953, https://doi.org/10.1183/13993003.01953-2017 (2018).
 2. Xie, J. et al. A 16-year retrospective surveillance report on the pathogenic features and antimicrobial susceptibility of Pseudomonas 
aeruginosa isolates from FAHJU in Guangzhou representative of Southern China. Microb Pathog. 110, 37–41, https://doi.
org/10.1016/j.micpath.2017.06.018 (2017).
 3. Del Barrio-Tofino, E. et al. Genomics and susceptibility profiles of extensively drug-resistant Pseudomonas aeruginosa isolates from 
Spain. Antimicrob Agents Chemother. 61(11), E01589–E01517, https://doi.org/10.1128/AAC.01589-17 (2017).
 4. Yayan, J., Ghebremedhin, B. & Rasche, K. Antibiotic resistance of Pseudomonas aeruginosa in pneumonia at a single university 
hospital center in Germany over a 10-year period. PLoS ONE. 10(10), e0139836, https://doi.org/10.1371/journal.pone.0139836 
(2015).
 5. Klockgether, J., Cramer, N., Wiehlmann, L., Davenport, C. F. & Tümmler, B. Pseudomonas aeruginosa genomic structure and 
diversity. Front. Microbio. 2, 150, https://doi.org/10.3389/fmicb.2011.00150 (2011).
 6. Oliver, A. et al. The increasing threat of Pseudomonas aeruginosa high-risk clones. Drug Resist Updat. 21-22, 41–59, https://doi.
org/10.1016/j.drup.2015.08.002 (2015).
 7. Fothergill, J., Winstanley, C. & James, C. E. Novel therapeutic strategies to counter Pseudomonas aeruginosa infections. Expert Rev. 
Anti Infect Ther. 10, 219–235, https://doi.org/10.1586/eri.11.168 (2012).
 8. Maraolo, A. E. et al. Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art. Expert 
Review of Anti-infective Therapy. 15(9), 861–871, https://doi.org/10.1080/14787210.2017.1367666 (2017).
 9. Hentzer, M. et al. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J. 22, 3803–3815, https://
doi.org/10.1093/emboj/cdg366 (2003).
 10. Hentzer, M. et al. Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. 
Microbiology. 148, 87–102, https://doi.org/10.1099/00221287-148-1-87 (2002).
 11. Pearson, J. P., Feldman, M., Iglewski, B. H. & Prince, A. Pseudomonas aeruginosa cell-to-cell signaling is required for virulence in a 
model of acute pulmonary infection. Infect. Immun. 68, 4331–4334, https://doi.org/10.1128/IAI.68.7.4331-4334.2000 (2000).
 12. Lee, J. & Zhang, L. The hierarchy quorum sensing network in Pseudomonas aeruginosa. Protein Cell. 6, 26–41, https://doi.
org/10.1007/s13238-014-0100-x (2015).
 13. Williams, P., Winzer, K., Chan, W. C. & Camara, M. Look who’s talking: communication and quorum sensing in the bacterial world. 
Philosophical Transactions of the Royal Society B 362, 1119–1134 (2007).
 14. Arashida, N. et al. Identification of novel long chain N-acylhomoserine lactones of chain length C20 from the marine phototrophic 
bacterium Rhodovulum sulfidophilum. Bioscience, Biotechnology, and Biochemistry. 82(10), 1683–1693, https://doi.org/10.1080/091
68451.2018.1490168 (2018).
 15. Fuqua, W. C., Winans, S. C. & Greenberg, E. P. Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive 
transcriptional regulators. J. Bacteriol. 176, 269–275 (1994).
 16. Freeman, J. A., Lilley, B. N. & Bassler, B. L. A genetic analysis of the functions of LuxN: a two-component hybrid sensor kinase that 
regulates quorum sensing in Vibrio harveyi. Mol. Microbiol. 35, 139–149, https://doi.org/10.1046/j.1365-2958.2000.01684.x (2000).
 17. McClean, K. H. et al. Quorum sensing and Chromobacterium violaceum: exploitation of violacein production and inhibition for the 
detection of N-acylhomoserine lactones. Microbiology. 143, 3703–3711 (1997).
 18. Swem, L. R. et al. A Quorum-Sensing Antagonist Targets Both Membrane-Bound and Cytoplasmic Receptors and Controls Bacterial 
Pathogenicity. Molecular Cell. 35(2), 143–153, https://doi.org/10.1016/j.molcel.2009.05.029 (2009).
 19. Grandclément, C., Tannières, M., Moréra, S., Dessaux, Y. & Faure, D. Quorum quenching: role in nature and applied developments. 
FEMS Microbiol Rev. 40(1), 86–116, https://doi.org/10.1093/femsre/fuv038 (2016).
 20. Diggle, S. P. et al. The Pseudomonas aeruginosa 4-quinolone signal molecules HHQ and PQS play multifunctional roles in quorum 
sensing and iron entrapment. Chem. Biol. 14, 87–96, https://doi.org/10.1016/j.chembiol.2006.11.014 (2007).
 21. Welsh, M. A. & Blackwell, H. E. Chemical genetics reveals environment-specific roles for quorum sensing circuits in Pseudomonas 
aeruginosa. Cell. Chem. Biol. 23, 361–369, https://doi.org/10.1016/j.chembiol.2016.01.006 (2016).
 22. Guendouze, A. et al. Effect of Quorum Quenching Lactonase in Clinical Isolates of Pseudomonas aeruginosa and Comparison with 
Quorum Sensing Inhibitors. Front Microbiol. 8, 227, https://doi.org/10.3389/fmicb.2017.00227 (2017).
 23. Koh, C. L. et al. Plant-derived natural products as sources of anti-quorum sensing compounds. Sensors (Basel). 13(5), 6217–28, 
https://doi.org/10.3390/s130506217 (2013).
1 2Scientific RepoRtS |         (2019) 9:16465  | https://doi.org/10.1038/s41598-019-52955-3
www.nature.com/scientificreportswww.nature.com/scientificreports/
 24. Yang, F. et al. Quorum quenching enzyme activity is widely conserved in the sera of mammalian species. FEBS Letters. 579, https://
doi.org/10.1016/j.febslet.2005.05.060 (2005).
 25. See-Too, W. S. et al. AidP, a novel N-Acyl homoserine lactonase gene from Antarctic Planococcus sp. Scientific reports. 7, 42968, 
https://doi.org/10.1038/srep42968 (2017).
 26. Aleksić, I. et al. Long-Chain 4-Aminoquinolines as Quorum Sensing Inhibitors in Serratia marcescens and Pseudomonas aeruginosa. 
ACS Chemical Biology. 12(5), 1425–1434, https://doi.org/10.1021/acschembio.6b01149 (2017).
 27. Guo, H. et al. Comparative Genomic Analysis of Delftia tsuruhatensis MTQ3 and the Identification of Functional NRPS Genes for 
Siderophore Production. BioMed Research International. 3687619, 8, https://doi.org/10.1155/2016/3687619 (2016).
 28. Tabak, O. et al. Port-related Delftia tsuruhatensis bacteremia in a patient with breast cancer. New Microbiol. 36, 199–201 (2013).
 29. Preiswerk, B., Ullrich, S., Speich, R., Bloemberg, G. V. & Hombach, M. Human infection with Delftia tsuruhatensis isolated from a 
central venous catheter. J Med Microbiol. 60, 246–8, https://doi.org/10.1099/jmm.0.021238-0 (2011).
 30. Ranc, A., Dubourg, G., Fournier, P., Raoult, D. & Fenollar, F. Delftia tsuruhatensis, an Emergent Opportunistic Healthcare-
Associated Pathogen. Emerg Infect Dis. 24(3), 594–596, https://doi.org/10.3201/eid2403.160939 (2018).
 31. Singh, V. K., Mishra, A. & Jha, B. Anti-quorum Sensing and Anti-biofilm Activity of Delftia tsuruhatensis Extract by Attenuating the 
Quorum Sensing-Controlled Virulence Factor Production in Pseudomonas aeruginosa. Front Cell Infect Microbiol. 7, 337, https://
doi.org/10.3389/fcimb.2017.00337 (2017).
 32. Leipert, J., Treitz, C., Leippe, M. & Tholey, A. Identification and Quantification of N-Acyl Homoserine Lactones Involved in Bacterial 
Communication by Small-Scale Synthesis of Internal Standards and Matrix-Assisted Laser Desorption/Ionization Mass 
Spectrometry. J Am Soc Mass Spectrom. 28(12), 2538–2547, https://doi.org/10.1007/s13361-017-1777-x (2017).
 33. Morin, D., Grasland, B., Vallée-Réhel, K., Dufau, C. & Haras, D. On-line high-performance liquid chromatography-mass 
spectrometric detection and quantification of N-acylhomoserine lactones, quorum sensing signal molecules, in the presence of 
biological matrices. J. Chromatogr. A. 1002, 79–92, https://doi.org/10.1016/S0021-9673(03)00730-1 (2003).
 34. Nguyen, D. H., Nguyen, D. T. M. & Kim, E. K. Effects of di-(2-ethylhexyl) phthalate (DEHP) released from laboratory equipments. 
Korean J. Chem. Eng. 25(5), 1136–1139, https://doi.org/10.1007/s11814-008-0186-z (2008).
 35. Reid, A. M., Brougham, C. A., Fogarty, A. M. & Roche, J. J. An investigation into possible sources of phthalate contamination in the 
environmental analytical laboratory. Int J Environ Anal Chem. 87(2), 125–133, https://doi.org/10.1080/03067310601071183 (2007).
 36. Singh, V. K. et al. Cis-9-octadecenoic acid from the rhizospheric bacterium Stenotrophomonas maltophilia BJ01 shows quorum 
quenching and anti-biofilm activities. Biofouling. 29(7), 855–867, https://doi.org/10.1080/08927014.2013.807914 (2013).
 37. Cho, H. S. et al. Inhibition of Pseudomonas aeruginosa and Escherichia coli O157:H7 biofilm formation by plant metabolite 
ϵ-viniferin. J. Agric. Food. Chem. 61(29), 7120–7126, https://doi.org/10.1021/jf4009313 (2013).
 38. Pearson, J. P., Pesci, E. C. & Iglewski, B. H. Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of 
elastase and rhamnolipid biosynthesis genes. J. Bacteriol. 179, 5756–5767 (1997).
 39. Lau, G. W., Hassett, D. J., Ran, H. & Kong, F. The role of pyocyanin in Pseudomonas aeruginosa infection. Trends Mol. Med. 10, 
599–606, https://doi.org/10.1016/j.molmed.2004.10.002 (2004).
 40. Ding, X. et al. Screening for novel quorum-sensing inhibitors to interfere with the formation of Pseudomonas aeruginosa biofilm. J. 
Med. Microbiol. 60(12), 1827–1834, https://doi.org/10.1099/jmm.0.024166-0 (2011).
 41. Yang, Y. et al. A new quorum-sensing inhibitor attenuates virulence and decreases antibiotic resistance in Pseudomonas aeruginosa. 
Journal of Microbiology 50, 987–993, https://doi.org/10.1007/s12275-012-2149-7 (2012).
 42. Marketon, M. M. et al. Characterization of the Sinorhizobium meliloti sinR/sinI Locus and the Production of Novel N-Acyl 
Homoserine Lactones. Journal of Bacteriology. 184(20), 5686–5695, https://doi.org/10.1128/JB.184.20.5686-5695.2002 (2002).
 43. Chen, G. et al. A Strategy for Antagonizing Quorum Sensing. Mol Cell. 42(2), 199–209, https://doi.org/10.1016/j.molcel.2011.04.003 
(2011).
 44. Soukarieh, F., Williams, P., Stocks, M. J. & Cámara, M. Pseudomonas aeruginosa Quorum Sensing Systems as Drug Discovery 
Targets: Current Position and Future Perspectives. Journal of Med Chem. 61(23), 10385–10402, https://doi.org/10.1021/acs.
jmedchem.8b00540 (2018).
 45. Zhu, J. et al. Analogs of the autoinducer 3-oxooctanoyl-homoserine lactone strongly inhibit activity of the TraR protein of 
Agrobacterium tumefaciens. J. Bacteriol. 180, 5398–5405 (1998).
 46. Filipic, B. et al. Uncovering Differences in Virulence Markers Associated with Achromobacter Species of CF and Non-CF Origin. 
Frontiers in cellular and infection microbiology. 7, 224, https://doi.org/10.3389/fcimb.2017.00224 (2017).
 47. Jovcic, B. et al. Emergence of NDM-1 Metallo-β-Lactamase in Pseudomonas aeruginosa Clinical isolates from Serbia. Ant Agents 
and Chem. 55(8), 3929–3931 (2011).
 48. Jovčić, B. et al. The clinical isolate Pseudomonas aeruginosa MMA83 carries two copies of the blaNDM-1 gene in a novel genetic 
context. Ant Agents and Chem. AAC. 02312–12 (2013).
 49. McLean, R. J. C., Pierson, L. S. & Fuqua, C. A simple screening protocol for the identification of quorum signal antagonists. J. 
Microbiol. Methods 58, 351–360, https://doi.org/10.1016/j.mimet.2004.04.016 (2004).
 50. Andrews, S. FastQC: a quality control tool for high throughput sequence data. Available online at: http://www.bioinformatics.
babraham.ac.uk/projects/fastqc (2010).
 51. Peng, Y., Leung, H. C., Yiu, S. M. & Chin, F. Y. IDBA-UD: a de novo assembler for single-cell and metagenomic sequencing data with 
highly uneven depth. Bioinformatics. 28(11), 1420–8, https://doi.org/10.1093/bioinformatics/bts174 (2012).
 52. Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 26(5), 589–95, https://
doi.org/10.1093/bioinformatics/btp698. (2010).
 53. Yoon, S. H. et al. Introducing EzBioCloud: a taxonomically united database of 16S rRNA gene sequences and whole-genome 
assemblies. Int J Syst Evol Microbiol. 67, 1613–1617, https://doi.org/10.1099/ijsem.0.001755 (2017).
 54. Liu, B., Zheng, D. D., Jin, Q., Chen, L. H. & Yang, J. VFDB 2019: a comparative pathogenomic platform with an interactive web 
interface. Nucleic Acids Res. 47(D1), D687–D692, https://doi.org/10.1093/nar/gky1080 (2019).
 55. McArthur, A. G. et al. The Comprehensive Antibiotic Resistance Database. Antimicrobial Agents and Chemotherapy. 57(7), 
3348–3357, https://doi.org/10.1128/AAC.00419-13 (2013).
 56. Wang, J., Quan, C., Wang, X., Zhao, P. & Fan, S. Extraction, purification and identification of bacterial signal molecules based on 
N-acyl homoserine lactones. Microbial Biotechnology 4, 479–490, https://doi.org/10.1111/j.1751-7915.2010.00197.x (2011).
 57. Chang, H. et al. Strain identification and quorum sensing inhibition characterization of marine-derived Rhizobium sp. NAO14 Royal 
Society Open Science https://doi.org/10.1098/rsos.170025 (2017).
 58. Stepanović, S. et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for 
assessment of biofilm production by staphylococci. APMIS 115, 891–899, https://doi.org/10.1111/j.1600-0463.2007.apm_630.x 
(2007).
 59. Milivojevic, D. et al. Biofilm-forming ability and infection potential of Pseudomonas aeruginosa strains isolated from animals and 
humans. Pathogens and Disease. 76(4), https://doi.org/10.1093/femspd/fty041 (2018).
 60. Odds, F. C. Synergy, antagonism, and what the chequerboard puts between them. J. Antimicrob. Chemother. 52, 1, https://doi.
org/10.1093/jac/dkg301 (2003).
 61. Alipour, M. et al. Attenuation of Pseudomonas aeruginosa virulence factors and biofilms by co-encapsulation of 
bismuth–ethanedithiol with tobramycin in liposomes. Journal of Antimicrobial Chemotherapy. 65(4.1), 684–693, https://doi.
org/10.1093/jac/dkq036 (2010).
13Scientific RepoRtS |         (2019) 9:16465  | https://doi.org/10.1038/s41598-019-52955-3
www.nature.com/scientificreportswww.nature.com/scientificreports/
 62. Rienzo, D. D., Kamalanathan, M. & Martin, P. Comparative study of the production of rhamnolipid biosurfactants by B. thailandensis 
E264 and P. aeruginosa ATCC 9027 using foam fractionation. Process Biochemistry. 51(7), 820–827, https://doi.org/10.1016/j.
procbio.2016.04.007 (2016).
 63. Saha, S., Thavasi, R. & Jayalakshami, S. Phenazine pigments from Pseudomonas aeruginosa and their application as antibacterial 
agent and food colourants. Research Journal of Microbiol. 3(3), 122–128, https://doi.org/10.3923/jm.2008.122.128 (2008).
 64. Essar, D. W., Eberly, L., Hadero, A. & Crawford, I. P. Identification and characterization of genes for a second anthranilate synthase 
in Pseudomonas aeruginosa: interchangeability of the two anthranilate synthases and evolutionary implications. Journal of 
Bacteriology. 172, 884–900 (1990).
 65. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCTmethod. 
Methods. 25, 402–408, https://doi.org/10.1006/meth.2001.1262 (2001).
Acknowledgements
This work was supported by the Ministry of Education, Science and Technological Development of the Republic 
of Serbia [Grant No. 173019]. MM was granted a Wood-Whelan Researcher Fellowship of International Union of 
Biochemistry and Molecular Biology. The Authors thank to Dr. Zorica Vasiljević, Dr. Dušan Milivojević, Dr. Vele 
Tešević and Dr. Goran Jovanović for their help.
Author contributions
B.J., M.K. and A.M. conceived the experiments, M.M., F.L., B.F., N.S., K.N. and L.S. conducted the experiments, 
B.J., M.K., A.M. and N.P. analyzed the results, F.D.L., N.P., M.K., A.M., B.F. and L.S. revised the manuscript. All 
authors reviewed and approved the manuscript.
competing interests
The authors declare no competing interests.
Additional information
Supplementary information is available for this paper at https://doi.org/10.1038/s41598-019-52955-3.
Correspondence and requests for materials should be addressed to B.J.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2019
